Quantifying The Impact Of AI-Enabled Trial Delivery
Source: Clinical Leader
In March 2026, consultants Brian Whitlock and Samir Shah presented data at the TD Cowen Healthcare Conference quantifying the impact of AI-enabled trial delivery on a hypothetical Phase III study. On 4/1/26, Clinical Leader hosted an exclusive webinar summarizing the data Whitlock and Shah presented. The webinar also included Mark Travers and Sheryl Jacobs, two other pharma executive consultants, who gave their views on the data, along with practical maturation timing and barriers in pharma clinical development.